Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians

Abstract

ObjectivesTo identify and explore barriers to, and enablers of, active surveillance (AS) in men with low‐risk prostate cancer (LRPCa), as perceived by PCa clinicians.Patients and MethodsUrologists and radiation oncologists in Australia and New Zealand were purposively sampled for a cross‐section on gender and practice setting (metropolitan/regional; public/private). Using a grounded theory approach, semi‐structed interviews were conducted with participants. Interviews were coded independently by two researchers using open, axial, and selective coding. A constant comparative approach was used to analyse data as it was collected. Thematic saturation was reached after 18 interviews, and a detailed model of barriers to, and enablers of, AS for LRPCa, as perceived by clinicians was developed.ResultsA model explaining what affects clinician decision making regarding AS in LRPCa emerged. It was underpinned by three broad themes: (i) clinician perception of patients’ barriers and enablers; (ii) clinician perception of their own barriers and enablers; and (iii) engagement with healthcare team and resource availability.ConclusionsClinicians unanimously agree that AS is an evidence‐based approach for managing LRPCa. Despite this many men do not undergo AS for LRPCa, which is due to the interplay of patient and clinician factors, and their interaction with the wider healthcare system. This study identifies strategies to mitigate barriers and enhance enablers, which could increase access to AS by patients with LRPCa.